We’re here to advance human health, by reimagining drug discovery with the power and pace of artificial intelligence. We believe there’s a fundamental symmetry in the universe between …

Isomorphic Labs was born in 2021 to apply AI and computational methods to drug discovery, and transform the way medicine helps and heals people. We’re building on the AlphaFold …

Isomorphic Labs Limited[1] is a London -based company which uses artificial intelligence for drug discovery. [2][3][4] Isomorphic Labs was founded by Demis Hassabis, who also serves as the …

Build a career while you build a company. Find out what it’s like to work here. This is usually a screening call (or two) where we learn more about each other. This is where we give you a …

Jan 21, 2025 · Isomorphic Labs, the four-year-old drug discovery start-up owned by Google parent Alphabet, will have an artificial intelligence-designed drug in trials by the end of this …

Oct 15, 2024 · Fresh off a Nobel Prize win, Google (GOOGL) DeepMind’s CEO and founder Demis Hassabis has no plans to slow down his A.I. ambitions. The computer scientist runs a …

Jan 7, 2024 · Isomorphic Labs is an autonomous subsidiary of Alphabet that was launched from Alphabet's DeepMind in 2021 to build on the success of AlphaFold, the company's …

Jan 10, 2024 · Isomorphic Labs uses an AI platform to predict biochemical structures, which aids the creation of new drugs by recommending which potential compounds will have the desired …

Jan 8, 2024 · Alphabet’s artificial intelligence start-up Isomorphic Labs has made a splash at the start of the JP Morgan Healthcare conference this week, announcing its first pharma …

5 days ago · Isomorphic Labs, a spinoff of Google's DeepMind, is set to take a significant leap in healthcare innovation by initiating clinical trials for drugs designed using artificial intelligence …